Stock analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a research note issued to investors on Wednesday. The firm set a "hold" rating on the stock.
Separately, Benchmark restated a "speculative buy" rating and issued a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.
Read Our Latest Report on Milestone Scientific
Milestone Scientific Price Performance
Shares of NYSE MLSS traded down $0.02 during midday trading on Wednesday, hitting $1.27. 127,258 shares of the company's stock were exchanged, compared to its average volume of 291,222. Milestone Scientific has a twelve month low of $0.54 and a twelve month high of $1.39. The firm has a market cap of $98.92 million, a P/E ratio of -18.14 and a beta of 1.10. The stock's 50 day moving average price is $0.98 and its 200-day moving average price is $0.93.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. World Investment Advisors LLC purchased a new stake in shares of Milestone Scientific in the third quarter valued at $91,000. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific during the 3rd quarter valued at about $48,000. Geode Capital Management LLC increased its holdings in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock valued at $480,000 after purchasing an additional 31,572 shares during the period. Finally, Carnegie Investment Counsel lifted its position in shares of Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock worth $166,000 after purchasing an additional 27,412 shares in the last quarter. Institutional investors own 5.79% of the company's stock.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Articles
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
